Filing Details
- Accession Number:
- 0001181431-14-020646
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-21 17:45:42
- Reporting Period:
- 2014-05-19
- Filing Date:
- 2014-05-21
- Accepted Time:
- 2014-05-21 17:45:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492426 | Horizon Pharma Inc. | HZNP | Pharmaceutical Preparations (2834) | 272179987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1523672 | N Todd Smith | C/O Horizon Pharma, Inc. 520 Lake Cook Road, Suite 520 Deerfield IL 60015 | Evp & Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-05-19 | 10,159 | $12.94 | 44,552 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Reflects shares of common stock surrendered via open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2012, in order to satisfy certain tax withholding obligations.
- The shares were sold in three block trades at prices ranging from $12.92 to $12.95, and the price reported in the table reflects the weighted average sale price for such block trades. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Includes 11,975 shares of the Company's common stock acquired pursuant to an employee stock purchase program.
Billionaire Hedge Funds
